These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37795549)

  • 1. Extracellular vesicles in plasma and cerebrospinal fluid in patients with COVID-19 and neurological symptoms.
    Taxiarchis A; Bellander BM; Antovic J; Soutari N; Virhammar J; Kumlien E; Karakoyun C; Rostami E; Antovic A
    Int J Lab Hematol; 2024 Feb; 46(1):42-49. PubMed ID: 37795549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Expression of Extracellular Vesicles Is Associated With the Procoagulant State in Patients With Established Rheumatoid Arthritis.
    Stojanovic A; Veselinovic M; Zong Y; Jakovljevic V; Pruner I; Antovic A
    Front Immunol; 2021; 12():718845. PubMed ID: 34394126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased circulating platelet-derived extracellular vesicles in severe COVID-19 disease.
    Helin T; Palviainen M; Lemponen M; Maaninka K; Siljander P; Joutsi-Korhonen L
    Platelets; 2024 Dec; 35(1):2313362. PubMed ID: 38380806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic Profile of Procoagulant Extracellular Vesicles Reflects Complement System Activation and Platelet Hyperreactivity of Patients with Severe COVID-19.
    Moraes ECDS; Martins-Gonçalves R; da Silva LR; Mandacaru SC; Melo RM; Azevedo-Quintanilha I; Perales J; Bozza FA; Souza TML; Castro-Faria-Neto HC; Hottz ED; Bozza PT; Trugilho MRO
    Front Cell Infect Microbiol; 2022; 12():926352. PubMed ID: 35937696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatidylserine Exposing Extracellular Vesicles in Pre-eclamptic Patients.
    Lalic-Cosic S; Dopsaj V; Kovac M; Mandic-Markovic V; Mikovic Z; Mobarrez F; Antovic A
    Front Med (Lausanne); 2021; 8():761453. PubMed ID: 34805227
    [No Abstract]   [Full Text] [Related]  

  • 6. Procoagulant extracellular vesicles in amniotic fluid.
    Hell L; Wisgrill L; Ay C; Spittler A; Schwameis M; Jilma B; Pabinger I; Altevogt P; Thaler J
    Transl Res; 2017 Jun; 184():12-20.e1. PubMed ID: 28236427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation potential and the integrated omics of extracellular vesicles from COVID-19 positive patient plasma.
    Setua S; Thangaraju K; Dzieciatkowska M; Wilkerson RB; Nemkov T; Lamb DR; Tagaya Y; Boyer T; Rowden T; Doctor A; D'Alessandro A; Buehler PW
    Sci Rep; 2022 Dec; 12(1):22191. PubMed ID: 36564503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled trial protocol to investigate the antiplatelet therapy effect on extracellular vesicles (AFFECT EV) in acute myocardial infarction.
    Gasecka A; Nieuwland R; Budnik M; Dignat-George F; Eyileten C; Harrison P; Huczek Z; Kapłon-Cieślicka A; Lacroix R; Opolski G; Pluta K; van der Pol E; Postuła M; Leroyer A; Siljander P; Sturk A; Filipiak KJ
    Platelets; 2020; 31(1):26-32. PubMed ID: 30585111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 primed platelets-derived microRNAs enhance NETs formation by extracellular vesicle transmission and TLR7/8 activation.
    Liao TL; Liu HJ; Chen DY; Tang KT; Chen YM; Liu PY
    Cell Commun Signal; 2023 Oct; 21(1):304. PubMed ID: 37904132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic profiling of single extracellular vesicles reveals colocalization of SARS-CoV-2 with a CD81/integrin-rich EV subpopulation in sputum from COVID-19 severe patients.
    Sun R; Cai Y; Zhou Y; Bai G; Zhu A; Kong P; Sun J; Li Y; Liu Y; Liao W; Liu J; Cui N; Xiang J; Li B; Zhao J; Wu D; Ran P
    Front Immunol; 2023; 14():1052141. PubMed ID: 37251406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procoagulant Effects of Low-Level Platelet Activation and Its Inhibition by Colchicine.
    Reddel CJ; Pennings GJ; Curnow JL; Chen VM; Kritharides L
    Thromb Haemost; 2018 Apr; 118(4):723-733. PubMed ID: 29554700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Significance of Phenotyping and Quantification of Plasma Extracellular Vesicles Levels Using High-Sensitivity Flow Cytometry during COVID-19 Treatment.
    Kudryavtsev I; Kalinina O; Bezrukikh V; Melnik O; Golovkin A
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33925492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Tissue Factor and Platelet/Leukocyte Markers on Extracellular Vesicles Reflect Platelet-Leukocyte Interaction in Severe COVID-19.
    Eichhorn T; Weiss R; Huber S; Ebeyer-Masotta M; Mostageer M; Emprechtinger R; Knabl L; Knabl L; Würzner R; Weber V
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating brain-derived extracellular vesicles expressing neuroinflammatory markers are associated with HIV-related neurocognitive impairment.
    de Menezes EGM; Liu JS; Bowler SA; Giron LB; D'Antoni ML; Shikuma CM; Abdel-Mohsen M; Ndhlovu LC; Norris PJ
    Front Immunol; 2022; 13():1033712. PubMed ID: 36601110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular Vesicles: The Invisible Heroes and Villains of COVID-19 Central Neuropathology.
    Chang H; Chen E; Hu Y; Wu L; Deng L; Ye-Lehmann S; Mao X; Zhu T; Liu J; Chen C
    Adv Sci (Weinh); 2024 Mar; 11(10):e2305554. PubMed ID: 38143270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Platelet-Derived Extracellular Vesicles Are a Hallmark of Sars-Cov-2 Infection.
    Cappellano G; Raineri D; Rolla R; Giordano M; Puricelli C; Vilardo B; Manfredi M; Cantaluppi V; Sainaghi PP; Castello L; De Vita N; Scotti L; Vaschetto R; Dianzani U; Chiocchetti A
    Cells; 2021 Jan; 10(1):. PubMed ID: 33430260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood mononuclear cell tissue factor (F3 gene) transcript levels and circulating extracellular vesicles are elevated in severe coronavirus 2019 (COVID-19) disease.
    Girard TJ; Antunes L; Zhang N; Amrute JM; Subramanian R; Eldem I; Remy KE; Mazer M; Erlich EC; Cruchaga C; Steed AL; Randolph GJ; Di Paola J
    J Thromb Haemost; 2023 Mar; 21(3):629-638. PubMed ID: 36696180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular Vesicles of COVID-19 Patients Reflect Inflammation, Thrombogenicity, and Disease Severity.
    Aharon A; Dangot A; Kinaani F; Zavaro M; Bannon L; Bar-Lev T; Keren-Politansky A; Avivi I; Jacob G
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics characterization of extracellular vesicles sorted by flow cytometry reveals a disease-specific molecular cross-talk from cerebrospinal fluid and tears in multiple sclerosis.
    Pieragostino D; Lanuti P; Cicalini I; Cufaro MC; Ciccocioppo F; Ronci M; Simeone P; Onofrj M; van der Pol E; Fontana A; Marchisio M; Del Boccio P
    J Proteomics; 2019 Jul; 204():103403. PubMed ID: 31170500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel.
    Gasecka A; Nieuwland R; Budnik M; Dignat-George F; Eyileten C; Harrison P; Lacroix R; Leroyer A; Opolski G; Pluta K; van der Pol E; Postuła M; Siljander P; Siller-Matula JM; Filipiak KJ
    J Thromb Haemost; 2020 Mar; 18(3):609-623. PubMed ID: 31833175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.